Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02453620Phase 1Active Not Recruiting
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
PrincipalinvestigatorStart date: 2016-02-12
NCT01638533Phase 1Completed
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
PrincipalinvestigatorStart date: 2012-08-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmRecurrent Prostate Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GliomaLymphoma
Similarity Score1%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Lymphoma
Similarity Score1%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Lymphoma
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

Celgene CorporationNational Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02453620Phase 1PrincipalInvestigator

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
Active Not Recruiting
NCT01638533Phase 1PrincipalInvestigator

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
Completed

All 2 trials loaded